CVS Health Corp
CVSToday
-0.47%
5 Days
+3.95%
1 Month
+0.54%
6 Months
+26.02%
Year to Date
+24.75%
1 Year
+35.28%
Recent
Analysis
Danaher Corp Stock (DHR) Moved Down by 3.06% on Sep 1: Facts Behind the Movement
• Danaher narrowed its full-year core revenue growth projections following second-quarter results. • Outgoing leadership announced a transition alongside subsequent disclosures of executive share sales. • The company reported latest annual revenue of $24.57B and net profit of $3.61B.
Resmed Inc Stock (RMD) Moved Down by 3.25% on Sep 1: Facts Behind the Movement
• ResMed faces volatility from Astral ventilator sales suspensions and strategic portfolio adjustments. • Management reports under-penetrated sleep apnea markets despite ongoing debate over GLP-1 therapies. • The company generated $5.65B in annual revenue with net profit reaching $1.52B.
CVS Health Corp Stock (CVS) Moved Up by 3.29% on Sep 1: Facts Behind the Movement
• CVS Health gained following an institutional upgrade and strong earnings visibility. • Market rotation into defensive healthcare sectors supported buying interest amid broader volatility. • Annual revenue reached $402.07 billion with a net profit of $1.77 billion.
CVS Health Corp Stock (CVS) Moved Down by 3.46% on Aug 17: A Full Analysis
• CVS Health faced selling pressure despite raising its full-year earnings guidance. • Investors remain cautious regarding medical cost trends and Caremark structural changes. • Technical indicators show negative momentum with a MACD value of -2.245.
Resmed Inc Stock (RMD) Closed Down by 5.22% on Aug 7: What Investors Need To Know
• ResMed gross margins contracted due to product mix shifts and elevated logistical expenses. • Concerns over GLP-1 weight-loss drugs create long-term uncertainty for CPAP market growth. • Increased competition and higher operating expenses are pressuring short-term profitability and investor sentiment.
CVS Health Corp Stock (CVS) Moved Down by 4.65% on Aug 5: Drivers Behind the Movement
• CVS Health shares declined following an earnings report highlighting increased medical benefit ratios. • Management lowered full-year earnings guidance due to rising costs and retail pharmacy pressures. • Regulatory scrutiny regarding pharmacy benefit manager practices has introduced significant policy uncertainty.
CVS Health Corp's Score
Media Coverage
Analyst Rating
CVS Health Corp Technical Analysis
Technical Indicators
Summary
Moving Average
Financial Indicators
Earnings
CVS Health Corp Profile
Ownership
| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.48% |
| Capital World Investors | 5.30% |
| BlackRock Institutional Trust Company, N.A. | 5.09% |
| Dodge & Cox | 4.90% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 47.14% |
| Investment Advisor/Hedge Fund | 30.56% |
| Hedge Fund | 3.66% |
| Research Firm | 2.90% |
Related Instruments
Popular Instruments
